Related Experiment Videos

Renal biopsy specimens from patients with rheumatoid arthritis and apparently normal renal function after therapy

D Ludwin1, I Alexopoulou, J M Esdaile

  • 1Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Insights

Low-dose cyclosporine in rheumatoid arthritis patients showed minimal kidney changes on biopsy, but caution is advised due to potential long-term renal effects.

Area of Science:

  • Nephrology
  • Rheumatology
  • Immunosuppression

Background:

  • Rheumatoid arthritis (RA) patients often have underlying renal issues.
  • Cyclosporine is an immunosuppressant used in RA treatment.
  • Assessing cyclosporine's renal safety in RA is crucial.

Purpose of the Study:

  • To evaluate renal biopsy findings in severe rheumatoid arthritis patients treated with low-dose cyclosporine.
  • To identify potential cyclosporine-induced nephropathy in this patient cohort.

Main Methods:

  • Renal biopsies were performed on 14 patients with severe RA after cyclosporine treatment.
  • Patients had no pre-existing compromised renal function.
  • Serum creatinine levels were monitored.

Main Results:

  • Most biopsies showed minimal changes after 6 months of cyclosporine.
  • Mild glomerular expansion, obsolescence, and amyloid deposits were noted in some patients.
  • One patient exhibited moderate interstitial fibrosis attributed to cyclosporine.

Conclusions:

  • Low-dose cyclosporine appears to cause minimal renal pathology in RA patients.
  • Long-term cyclosporine therapy requires caution in RA patients due to potential risks.
  • The utility of renal biopsies in preventing end-stage renal failure needs further investigation.

Related Concept Videos